11-74491959-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001144869.3(LIPT2):c.*176C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.588 in 592,680 control chromosomes in the GnomAD database, including 104,625 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.55 ( 23586 hom., cov: 31)
Exomes 𝑓: 0.60 ( 81039 hom. )
Consequence
LIPT2
NM_001144869.3 3_prime_UTR
NM_001144869.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.800
Genes affected
LIPT2 (HGNC:37216): (lipoyl(octanoyl) transferase 2) This gene encodes a mitochondrial protein that catalyzes the transfer of octanoic acid to lipoate-dependent enzymes such as octanoyl-ACP. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-74491959-G-A is Benign according to our data. Variant chr11-74491959-G-A is described in ClinVar as [Benign]. Clinvar id is 1277061.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.632 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LIPT2 | NM_001144869.3 | c.*176C>T | 3_prime_UTR_variant | 2/2 | ENST00000310109.5 | ||
LIPT2 | NM_001329941.2 | c.*286C>T | 3_prime_UTR_variant | 2/2 | |||
LIPT2 | NM_001329942.2 | c.*286C>T | 3_prime_UTR_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LIPT2 | ENST00000310109.5 | c.*176C>T | 3_prime_UTR_variant | 2/2 | 2 | NM_001144869.3 | P1 | ||
LIPT2 | ENST00000527115.1 | c.*286C>T | 3_prime_UTR_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.549 AC: 83306AN: 151676Hom.: 23596 Cov.: 31
GnomAD3 genomes
AF:
AC:
83306
AN:
151676
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.602 AC: 265319AN: 440886Hom.: 81039 Cov.: 3 AF XY: 0.598 AC XY: 138096AN XY: 231052
GnomAD4 exome
AF:
AC:
265319
AN:
440886
Hom.:
Cov.:
3
AF XY:
AC XY:
138096
AN XY:
231052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.549 AC: 83322AN: 151794Hom.: 23586 Cov.: 31 AF XY: 0.543 AC XY: 40271AN XY: 74140
GnomAD4 genome
AF:
AC:
83322
AN:
151794
Hom.:
Cov.:
31
AF XY:
AC XY:
40271
AN XY:
74140
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1807
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at